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Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in a zebrafish
model of RB1 embryonal brain tumor, and are required for neural
progenitor survival and proliferation
Abstract
In this study, we used comparative genomics and developmental genetics to identify epigenetic regulators
driving oncogenesis in a zebrafish retinoblastoma 1 (rb1) somatic-targeting model of RB1 mutant embryonal
brain tumors. Zebrafish rb1 brain tumors caused by TALEN or CRISPR targeting are histologically similar to
human central nervous system primitive neuroectodermal tumors (CNS-PNETs). Like the human
oligoneural OLIG2+/SOX10+ CNS-PNET subtype, zebrafish rb1 tumors show elevated expression of neural
progenitor transcription factors olig2, sox10, sox8b and the receptor tyrosine kinase erbb3a oncogene.
Comparison of rb1 tumor and rb1/rb1 germline mutant larval transcriptomes shows that the altered
oligoneural precursor signature is specific to tumor tissue. More than 170 chromatin regulators were
differentially expressed in rb1 tumors, including overexpression of chromatin remodeler components histone
deacetylase 1 (hdac1) and retinoblastoma binding protein 4(rbbp4). Germline mutant analysis confirms that
zebrafish rb1, rbbp4 and hdac1 are required during brain development. rb1 is necessary for neural precursor
cell cycle exit and terminal differentiation, rbbp4 is required for survival of postmitotic precursors, and hdac1
maintains proliferation of the neural stem cell/progenitor pool. We present an in vivo assay using somatic
CRISPR targeting plus live imaging of histone-H2A.F/Z-GFP fusion protein in developing larval brain to
rapidly test the role of chromatin remodelers in neural stem and progenitor cells. Our somatic assay
recapitulates germline mutant phenotypes and reveals a dynamic view of their roles in neural cell populations.
Our study provides new insight into the epigenetic processes that might drive pathogenesis in RB1 brain
tumors, and identifies Rbbp4 and its associated chromatin remodeling complexes as potential target pathways
to induce apoptosis in RB1 mutant brain cancer cells.
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RESEARCH ARTICLE
Epigenetic regulators Rbbp4 and Hdac1 are overexpressed in
a zebrafish model of RB1 embryonal brain tumor, and are required
for neural progenitor survival and proliferation
Laura E. Schultz1, Jeffrey A. Haltom1, Maira P. Almeida1, Wesley A. Wierson1, Staci L. Solin1,*, Trevor
J. Weiss1, Jordan A. Helmer1, Elizabeth J. Sandquist1, Heather R. Shive2 and Maura McGrail1,‡
ABSTRACT
In this study, we used comparative genomics and developmental
genetics to identify epigenetic regulators driving oncogenesis in a
zebrafish retinoblastoma 1 (rb1) somatic-targeting model of RB1
mutant embryonal brain tumors. Zebrafish rb1 brain tumors caused by
TALEN or CRISPR targeting are histologically similar to human central
nervous system primitive neuroectodermal tumors (CNS-PNETs).
Like the human oligoneural OLIG2+/SOX10+ CNS-PNET subtype,
zebrafish rb1 tumors show elevated expression of neural progenitor
transcription factors olig2, sox10, sox8b and the receptor tyrosine
kinase erbb3a oncogene. Comparison of rb1 tumor and rb1/rb1
germline mutant larval transcriptomes shows that the altered
oligoneural precursor signature is specific to tumor tissue. More than
170 chromatin regulators were differentially expressed in rb1 tumors,
including overexpression of chromatin remodeler components histone
deacetylase 1 (hdac1) and retinoblastoma binding protein 4 (rbbp4).
Germlinemutant analysis confirms that zebrafish rb1, rbbp4 and hdac1
are required during brain development. rb1 is necessary for neural
precursor cell cycle exit and terminal differentiation, rbbp4 is required
for survival of postmitotic precursors, and hdac1maintains proliferation
of the neural stem cell/progenitor pool. We present an in vivo assay
using somatic CRISPR targeting plus live imaging of histone-H2A.F/
Z-GFP fusion protein in developing larval brain to rapidly test the role of
chromatin remodelers in neural stem and progenitor cells. Our somatic
assay recapitulates germline mutant phenotypes and reveals a
dynamic view of their roles in neural cell populations. Our study
provides new insight into the epigenetic processes that might drive
pathogenesis in RB1 brain tumors, and identifies Rbbp4 and its
associated chromatin remodeling complexes as potential target
pathways to induce apoptosis in RB1 mutant brain cancer cells.
This article has an associated First Person interview with the first
author of the paper.
KEY WORDS: Zebrafish, Rbbp4, Hdac1, RB1 embryonal oligoneural
brain tumor, Epigenetic regulators, CRISPR somatic targeting,
Neural progenitor
INTRODUCTION
The retinoblastoma tumor suppressor Retinoblastoma 1 (RB1) plays
distinct roles in regulating proliferation and differentiation in stem,
progenitor and lineage-restricted cell populations (Fong and Slack,
2017; Julian and Blais, 2015; Sage, 2012). The canonical tumor
suppressor role of RB1 is to regulate proliferation by transcriptional
repression of E2F targets driving cell cycle entry (Dyson, 2016). RB1
might also function as a tumor suppressor by promoting differentiation
of lineage-committed cells (Calo et al., 2010) and survival of
postmitotic neurons (Naser et al., 2016; Vandenbosch et al., 2016),
and preventing cellular reprogramming (Kareta et al., 2015). RB1
transcriptional control is mediated, in part, through association with
chromatin remodelers that modify post-translational marks on histones
to activate or repress gene expression (Beshiri et al., 2012; Brehm et al.,
1998; Lin et al., 2011). Like RB1, many chromatin remodelers are
mutated in human cancers (Vogelstein et al., 2013), implicating
epigenetic control of gene expression as a significant contributor to
oncogenesis (Conway et al., 2015; Suva et al., 2013). Recent analyses
of the epigenome in human and mouse retinoblastoma show that
histone modification correlates with oncogenic gene expression (Aldiri
et al., 2017; Benavente et al., 2013; Zhang et al., 2012). Understanding
how RB1 loss affects epigenetic control in neural stem and progenitor
cells during development and in brain cancer is important for
identifying new pathways that contribute to carcinogenesis.
Two epigenetic regulators that directly interact with RB1 are the
retinoblastoma binding protein RBBP4 (Qian and Lee, 1995; Qian
et al., 1993) and the Class I histone deacetylase HDAC1 (Brehm et al.,
1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998). RBBP4 is a
WD40-repeat histone chaperone (Burkhart and Sage, 2008; Murzina
et al., 2008; Nowak et al., 2011; Song et al., 2008) and a chromatin
adaptor component of multiple remodeling complexes, including the
nucleosome remodeling and histone deacetylase complex (NuRD)
(Alqarni et al., 2014) and the cell cycle regulatory DREAM complex
(Harrison et al., 2006; Litovchick et al., 2007). RBBP4 expression is
altered in human glioma (Forbes et al., 2017), and was recently shown
to cooperate with the p300 (EP300) histone acetyl transferase to
activate DNA repair pathway gene expression in glioblastoma cells
in response to temozolomide (Kitange et al., 2016). HDAC1 is a
component of NuRD and other repressive complexes which control
maintenance of stem cell pluripotency and cell differentiation
(Hayakawa and Nakayama, 2011). Studies in zebrafish show that
hdac1 is necessary for central and peripheral nervous system
development (Henion et al., 1996; Ignatius et al., 2013), and is
required for cell cycle exit and differentiation of neural precursors in
the retina (Stadler et al., 2005; Yamaguchi et al., 2005). The role of
HDAC1 in promoting proliferation versus differentiation could depend
on the type and location of the neural cell population examined
(Jaworska et al., 2015). Examining the contribution of HDAC1 andReceived 12 February 2018; Accepted 3 May 2018
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RBBP4 to maintaining the progenitor-like state of RB1 brain tumors
would shed light on the mechanism of chromatin remodeling in
epigenetic control of tumor suppression.
We previously demonstrated that genome editing nucleases can be
used to model brain tumors in zebrafish by targeted somatic
inactivation of the rb1 tumor suppressor gene (Solin et al., 2015).
Transcription activator-like effector nuclease (TALEN) targeting of
zebrafish rb1 leads to brain tumors with histological similarity to
central nervous system primitive neuroectodermal tumors (CNS-
PNETs) (Solin et al., 2015). The PNETs are a group of aggressive,
poorly differentiated tumors that feature neuroblast-like cells, which
suggests that this class of tumor originates from a progenitor
population that mirrors the embryonic neuroectoderm (Ostrom et al.,
2017; Chan et al., 2015). Recently, other zebrafish embryonal PNET
models have been created by somatic targeting or oncogene
overexpression. Targeting rb1 in a tp53 mutant background
produces medulloblastoma-like PNETs arising in the zebrafish
hindbrain (Shim et al., 2017). Activation of RAS/MAPK signaling
by NRAS overexpression in zebrafish oligoneural precursors leads to
PNETs (Modzelewska et al., 2016) that molecularly resemble the
human oligoneural PNET subtype, OLIG2+/SOX10+ CNS-PNET
(Picard et al., 2012; Sturm et al., 2016), defined by elevated expression
of the neural progenitor transcription factors OLIG2, SOX10, SOX8
and SOX2. Together, these models suggest that disruption of multiple
cellular pathways can lead to the formation of PNETs. Whether
epigenetic mechanisms also contribute to zebrafish embryonal PNET
oncogenesis, as suggested by genomic analyses of human and mouse
tumors, remains to be examined.
Here, we use transcriptomics, somatic and germline CRISPR/Cas9
mutagenesis, and live-cell imaging in zebrafish to identify candidate
RB1-interacting chromatin remodelers and examine their role in
neural stem and progenitor cells during development. Our analyses
provide new insight into the genomic processes that drive oncogenesis
in RB1 mutant brain tumors. Comparative transcriptome analysis of
zebrafish rb1 brain tumors with rb1/rb1 homozygous mutant tissue
suggests elevated expression of oligoneural precursor transcription
factors, and chromatin remodelers distinguish neoplastic from mutant
tissue. Isolation of rb1 germline mutants shows that in the developing
nervous system, rb1 is required cell autonomously to block cell cycle
re-entry in neural precursors. We demonstrate that the chromatin
remodeling adaptor and histone chaperone rbbp4 is necessary for the
survival of neural precursors, and that in the absence of rbbp4, neural
precursor cells undergo apoptosis. In contrast, hdac1 is necessary to
maintain proliferation in neural stem/progenitor cells. CRISPR
somatic targeting recapitulates germline mutagenesis phenotypes.
Live-cell imaging of histone H2A-GFP in mutant larvae reveals a
dynamic view of the effect of gene loss on neural stem and progenitor
cell division and survival. rb1 mutant neural precursors re-enter the
cell cycle but appear to stall in early mitosis, indicating a requirement
for zebrafish Rb1 in initiating quiescence as well as progression
through the cell cycle. Our genomic and phenotypic comparisons
indicate that in rb1 neoplastic cells, elevated levels of rbbp4 and hdac1
might contribute to proliferation and survival. Together, these results
identify Rbbp4 and its associated chromatin remodelers as a potential
new target for inhibiting tumor cell survival by driving neural cancer
stem cells into apoptosis.
RESULTS
Zebrafish rb1 brain tumors model embryonal OLIG2+/SOX10+
CNS-PNETs
We previously developed a zebrafish rb1 brain tumor model that
resembles poorly differentiated primitive neuroectodermal tumors by
somatic targeting of zebrafish rb1 with TALENs (Solin et al., 2015).
Targeting produces mosaic adults that develop brain tumors at
4-5 months of age (Fig. 1A). To determine the molecular signature of
the zebrafish rb1 brain tumors, ten tumor-bearing adults were
dissected. Half of the tumor tissue was used for RNA isolation,
and half was embedded for histological analysis (Fig. 1A; Fig. S1).
RNA sequencing (RNA-Seq) libraries were prepared from the
ten tumor biological replicates and two pools of three normal adult
brains (Fig. S2) and analyzed for differentially expressed genes
(Tables S1-S3). E2F targets driving cell cycle entry were highly
upregulated, and Ingenuity Pathway Analysis (IPA) revealed
activation of mitosis, cell cycle, and DNA replication,
recombination and repair pathways (Fig. S3). Gene Set Enrichment
Analysis (GSEA) also indicated a positive correlation with RB1-E2F
oncogenic cell signaling and transcriptional regulation pathways, and
a negative correlation with neurological differentiation (Fig. S4).
These results are consistent with misregulation of RB1-dependent
pathways driving oncogenesis in the rb1 brain tumors.
We next compared the zebrafish rb1 brain tumor transcriptome to
other zebrafish brain tumor models and to human CNS-PNET. A set
of 120 genes most highly up- and downregulated in the human
OLIG2+/SOX10+ CNS-PNET subtype (Picard et al., 2012) was
previously used to analyze differential gene expression in a zebrafish
NRAS CNS-PNET model (Modzelewska et al., 2016). The zebrafish
rb1 brain tumors showed a similar pattern of differential gene
expression across the 60 up- and 60 downregulated genes. Defining
factors of the human oligoneural CNS-PNET subgroup, olig2, sox10,
sox8b and erbb3a, and the stem/progenitor marker sox2 (Fig. 1B;
Tables S2 and S3) were upregulated in the zebrafish rb1 tumors.
Histopathological analyses of the remaining tumor tissue from the
individuals used for transcriptome analyses were consistent with a
proliferative, primitive neuroectodermal-like tumor (Fig. 1C-L; Fig.
S1). In the diencephalon/pretectal region of wild-type adult
zebrafish brain, Olig2, Sox2 and Sox10 immunolabeling is
normally restricted to cells lining the ventricles and regions
adjacent to the ventricular zone (Fig. 1C-G), where stem and
progenitor cells are located. Immunolabeling of zebrafish rb1
tumors confirmed high levels of expression of Olig2, Sox2 and
Sox10 and numerous phosphohistone H3-positive mitotic cells
scattered throughout the lesion (Fig. 1H-L). Together, these results
demonstrate the zebrafish rb1 brain tumors have a highly
proliferative, poorly differentiated state with an oligoneural
precursor molecular signature found in human OLIG2+/SOX10+
and zebrafish NRAS CNS-PNETs.
Zebrafish rb1 is required cell autonomously for neural
precursor cell cycle exit and terminal differentiation during
development
Transcriptome and molecular analysis of zebrafish rb1 tumors
indicated that an oligoneural precursor phenotype drives tumor
proliferation. To identify additional molecular and genomic changes
that underlie transformation and oncogenesis in the absence of RB1,
we generated RNA-Seq libraries from larval zebrafish homozygous
for a recessive loss of function rb1 mutation. The rb1/rb1 mutant
transcriptome was used for comparative analysis with the tumor
transcriptome to identify molecular pathways that distinguish
transformed rb1 tumor cells from nontransformed rb1/rb1
mutant cells.
We previously isolated a 7 bp frameshift mutation in rb1 exon 2,
rb1Δ7is54, and found that the allele is homozygous lethal during the
larval stage between 5 and 10 days postfertilization (dpf) (Solin
et al., 2015). To generate the rb1Δ7/Δ7 transcriptome, 5 dpf larvae
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were collected from an incross between two heterozygous rb1Δ7/+
adults. rb1Δ7/Δ7 homozygotes do not show a dramatic gross
morphological difference from wild-type or heterozygous siblings,
other than the absence of a swim bladder. To confirm larval
genotypes, larvae were dissected through the hindbrain; the head
was placed in TRIzol and the trunk tissue used for genotyping
(Fig. 2A). Five confirmed wild-type +/+ and homozygous rb1Δ7/
Δ7 heads were pooled in triplicate and used to prepare RNA-Seq
Fig. 1. Zebrafish rb1 brain tumors express an oligoneural precursor signature similar to human OLIG2+/SOX10+ CNS-PNET. (A) Zebrafish rb1 brain
tumor model created by somatic targeting of rb1 exon 2 with CRISPR-Cas9 or TALENs. Gross brain tumors develop in the midbrain and hindbrain (red asterisks)
of adults at 4-5 months of age. For transcriptome analysis, half of the tumor tissue was dissected from ten tumor-positive fish for RNA isolation. The remaining
tissue was embedded for pathology and immunolabeling. (B) Heat maps of log2(FPKM) show differential gene expression in zebrafish rb1 brain tumor
transcriptome of 120 genes in the humanOLIG2+/SOX10+CNS-PNET subtype. rb1 tumor RNA-Seq of ten biological replicates from ten individual tumor positive
adults, and C RNA-Seq of two biological replicates of three pooled normal adult zebrafish brain, are shown. (C-L) Histological and immunolabeling of wild-type
adult zebrafish pretectum/diencephalon (C-G) and tumor-containing brain tissue from transcriptome individual T2 (H,I) and T8 (J-L). Neoplastic cells in T2 tumor
show small densely basophilic nuclei, consistent with primitive neuroectodermal-like tumors (H,I). In normal adult brain, Olig2, Sox2 and Sox10 labeling is
restricted to cells at or adjacent to the ventricle (E-G). High levels of Olig2, Sox2 and Sox10 are detected in the neoplastic tissue in tumor T8. Phosphohistone H3-
labeled mitotic cells are scattered throughout the lesion (J-L). Scale bars: 200 µm (C,H); 50 µm (E,F,G,J,K,L).
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libraries (Fig. 2A; Fig. S5, Table S4). Differential gene expression
analysis of the rb1/rb1 mutant larval transcriptome (Tables S5 and
S6) showed upregulation of E2F targets driving cell cycle entry and
IPA pathways controlling cell division, mitosis, and DNA
replication, recombination and repair (Fig. S6), as expected for
activation of E2F-dependent pathways in the absence of RB1. The
Fig. 2. Zebrafish rb1Δ7/Δ7 homozygous mutant larval brain transcriptome and neurogenic phenotype. (A) Zebrafish rb1/rb1 mutant transcriptome was
generated from rb1Δ7/Δ7 homozygous and +/+ wild-type siblings from a cross between heterozygous rb1Δ7/+ adults. Heads from 5 dpf larva were dissected and
trunk tissue genotyped. Three pools of five heads of each genotype were used to generate RNA-Seq libraries. (B,C) Wild-type (B) and rb1Δ7/Δ7 (C) 5 dpf larvae.
(D) Diagram of larval midbrain and retina with location of neural stem and progenitor cells at brain ventricle (V) in the optic tectum (OT) and thalamic region (Th),
and at the retina ciliary marginal zone (cmz). Mature, postmitotic neurons are located in the lateral brain parenchyma and inner retina. (E-L) Immunolocalization
with neural differentiation marker HuC/D and mitotic M-phase marker phosphohsitone H3 (E,F,I,J). Wild-type brain and retina show the organization of mature
neurons in dorsal brain optic tectum (OT), ventral brain thalamus (Th), and laminated layers of the retina (gcl, ganglion cell layer; inl, inner nuclear layer; onl, outer
nuclear layer). Only one mitotic cell is detected at the brain ventricle (F, arrow). Mutant brain shows M-phase cells scattered throughout the midbrain tectum and
thalamus (G,H). In the retina, numerous M-phase cells are present across the entire inner nuclear layer, with occasional cells in the outer nuclear and ganglion
cell layer (K,L). (M,N) Quantification of pH3-positive cells in midbrain (M) and retina (N) sections from +/+ and rb1Δ7/Δ7 individual 5 dpf larvae (n=16 for each
genotype). Data are mean±s.e.m. P-values calculated by two-tailed unpaired Student’s t-test. Scale bars: 200 µm (B,C); 50 µm (E,I,G,K); 20 µm (F,J,H,L).
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results were remarkably similar to the rb1 brain tumor
transcriptome, suggesting that the activation of molecular
pathways driving cell proliferation is controlled by similar
mechanisms in rb1/rb1 mutant and rb1-transformed cells.
To confirm the proliferative phenotype of rb1/rb1 mutant cells,
brain sections of 5 dpf rb1/rb1 mutant larvae were labeled with
proliferation and differentiation markers and showed an increase in
mitotic-phase cells in the developing brain and retina (Fig. 2B-L). In
wild-type midbrain, cycling cells are restricted to proliferative zones
at the dorsal surface, ventricles and lateral edges of the brain
(Fig. 2E,F), and at the ciliary marginal zone at the periphery of
the retina (Fig. 2I,J), but are rarely captured in M phase by
phosphohistone H3 labeling (Fig. 2E,F, boxed region and arrow,
respectively). Phosphohistone H3-labeled cells are absent from the
brain parenchyma (Fig. 2F) and mature retina (Fig. 2J), where
the cell bodies of postmitotic differentiated neurons expressing the
neuronal RNA binding protein HuC/D-Elavl3 are located in wild-
type brain tissue. In contrast, in the rb1/rb1 mutant larvae, ectopic
phosphohistone H3-positive cells were detected throughout the
midbrain optic tectum and thalamus (Fig. 2G,H), and in the inner
and outer nuclear layers of the mature retina (Fig. 2K,L), at numbers
significantly greater than in wild type (Fig. 2M,N; Table S7).
Ectopic proliferation in the rb1/rb1 mutant was also detected in the
forebrain, cerebellum and hindbrain, along the entire anterior-
posterior axis (Fig. S7). Close examination of the rb1/rb1 mutant
phosphohistone H3-positive cells showed no labeling with HuC/D
(Fig. S8), suggesting that the cells were in a cycling progenitor-like
state. These results are consistent with a requirement for RB1 in
neural precursor cell cycle exit and terminal differentiation.
To examine whether the requirement for RB1 in neural precursor
cell cycle exit was cell autonomous, genetic mosaics were created
by transplanting rb1/rb1 mutant cells from blastula-stage embryos
into wild-type host embryos and examining their behavior in
larval brain. Embryos from heterozygous rb1Δ7/+ crossed to
heterozygous rb1Δ7/+;Tg(Tol2<ubi:DsRed2>) adults carrying a
ubiquitous RFP reporter transgene were collected, and cells from
blastula-stage embryos were transplanted into a casper host embryo.
The remaining donor embryo tissue was used to determine the rb1
genotype (Fig. S9). Three host larvae containing cells from a +/+ or
rb1Δ7/Δ7 donor embryo were analyzed. At 5 dpf, host larvae were
sectioned and co-labeled with antibodies against DsRed2, to
identify the descendants of transplanted cells, or the proliferation
marker phosphohistone H3 or the neuronal differentiation marker
HuC/D (Fig. 3). The descendants of +/+ wild-type (Fig. 3A,B,E,F)
and rb1Δ7/Δ7 mutant (Fig. 3C,D,G,H) transplanted cells were
incorporated into the developing brain and could be detected in the
midbrain parenchyma. None of the +/+ wild-type cells were labeled
with phosphohistone H3 (Fig. 3A,B), and each cell was positive for
the neuronal marker HuC/D (Fig. 3E,F). The majority of the rb1Δ7/
Δ7 mutant cells were phosphohistone H3 negative. However, in
each section, one or two phosphohistone H3-positive mutant cells
with highly condensed chromatin were detected (Fig. 3C,D),
indicating that the cells were in M phase. Each of the rb1Δ7/Δ7
mutant cells expressed HuC/D, except for the M-phase cells with
condensed chromatin (Fig. 3G,H, arrows). Higher magnification
images show that each wild-type (Fig. 3I-L) or rb1Δ7/Δ7 mutant
(Fig. 3M-P) cell that labels positively for HuC/D and DsRed2
contains chromatin characteristic of interphase cells. In contrast, the
rb1Δ7/Δ7 mutant cells with highly condensed chromatin do not
co-label with HuC/D (Fig. 3M-P). The presence of rb1Δ7/Δ7 cells
that express HuC/D/Elavl3 and rb1Δ7/Δ7 cells with condensed
chromatin in M phase suggests the mutant neural precursors are able
to re-enter the cell cycle. These results demonstrate that the
requirement for RB1 to block cell cycle entry in neural precursors is
cell autonomous.
Comparison of zebrafish rb1 tumor and rb1/rb1mutant
transcriptomes suggests that epigenetics drive rb1 tumor
growth
The rb1Δ7/Δ7 mutant transcriptome and phenotypic analyses
showed that rb1/rb1 mutant cells can re-enter the cell cycle and
proceed into M phase, but lack continuous unregulated proliferation
characteristic of rb1-transformed tumor cells. To gain insight into
the molecular differences between rb1/rb1 mutant and rb1-
transformed cells, we performed additional comparative analyses
between the zebrafish rb1 mutant and brain tumor transcriptomes.
We focused on transcriptional regulators which include epigenetic
chromatin remodelers and transcription factors, because a number
of studies indicate that regulation of the epigenome is a critical
component of oncogenesis (Suva et al., 2013).
Of the 3302 transcriptional regulators in the zebrafish genome
(Armant et al., 2013), 1191 were differentially expressed in the rb1
tumor transcriptome, and 122 were differentially expressed in the
rb1/rb1 mutant transcriptome (Tables S3 and S6). The majority of
the differentially expressed transcriptional regulators in both
transcriptomes were transcription factors; approximately one fifth
were chromatin regulators (Fig. 4A). However, elevated expression
of stem and neural progenitor transcription factors sox2, sox8,
sox10, olig2 and ascl1b, and downregulation of proneurogenic
transcription factors pax6a, pax2a, neurod1 and neurod6a, was
unique to the tumor (Fig. 4B). olig2 [tumor 11.2-fold, Benjamini–
Hochberg adjusted P-value (Padj)<0.00001; mutant 1.1-fold, Padj=
0.71904] and ascl1b (tumor 18-fold, Padj<0.00001; mutant 0.9-
fold, Padj=0.69777) levels were confirmed by quantitative reverse
transcription polymerase chain reaction (qRT-PCR) (Table S8) in
rb1 tumor tissue compared with normal adult brain (Fig. 4C), and in
the 5 dpf rb1/rb1mutant larvae compared with wild type (Fig. 4D).
The chromatin adaptor rbbp4, a component of multiple chromatin
remodelers controlling gene expression including NuRD, PRC2,
histone acetyltransferase p300 and the cell cycle DREAM/MuvB
complex, was upregulated in both rb1 tumor (7.8-fold,Padj<0.00001)
and rb1/rb1mutant (2.3-fold,Padj<0.00001) transcriptomes (Fig. 4B,
asterisk; Tables S3 and S6). Like rbbp4, hdac1, the catalytic
component of NuRD, and mbd3a, a DNA binding subunit, were
both significantly overexpressed in the rb1 tumor (hdac1 3.6-fold,
Padj<0.00001; mbd3a 6.1-fold, Padj<0.00001). Although hdac1 and
mbbd3awere also upregulated in the rb1/rb1mutant (hdac1 1.3-fold,
Padj=0.00123; mbd3a 1.2-fold, Padj=0.06262), neither was as
highly elevated as rbbp4. qRT-PCR confirmed the change in gene
expression for rbbp4 and hdac1 in rb1 tumor tissue (Fig. 4C) and in
the 5 dpf rb1/rb1 mutant larvae (Fig. 4D). The differences in gene
expression between tumor and mutant suggest that expression of
neural stem and progenitor transcription factors, together with altered
chromatin remodeler activity, correlates with transformation of rb1
mutant cells, maintenance of the tumor progenitor-like state and
tumor oncogenesis.
Distinct requirements for chromatin remodelers rbbp4 and
hdac1 in neurogenesis
To investigate how rbbp4 and hdac1 drive zebrafish rb1 brain
tumorigenesis, we isolated stable germline loss of function
mutations in each and examined their role in neural development.
CRISPR-Cas9 gene editing was used to generate a frameshift
mutation in exon 2 of rbbp4 (Fig. 5A-C) and exon 5 of
5
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hdac1 (Fig. 5D-F). A recessive lethal loss-of-function 4 bp deletion
mutation line was established for each, designated rbbp4Δ4is60 and
hdac1Δ4is70. Homozygous mutant rbbp4Δ4/Δ4 larvae are lethal
between 5 and 10 dpf and show a severe neurogenic phenotype with
microcephaly and microphthalmia (Fig. 5C). Similar to the
previously published colgate (hdac1) mutant (Henion et al., 1996;
Ignatius et al., 2008), homozygous mutant hdac1Δ4/Δ4 are also
larval lethal, and at 3 dpf show a reduced body size, curved trunk,
microcephaly and coloboma in the retina (Fig. 5F, arrow).
Homozygous mutant larvae were examined at 2 dpf to determine
the defect underlying the reduced size of the brain and retina
(Fig. 5G-J). In 2 dpf wild-type larval brain and retina, only a few
apoptotic cells were labeled with an antibody against activated
caspase 3 (Fig. 5H). rbbp4Δ4/Δ4 mutants showed extensive
apoptosis in the midbrain optic tectum and retina, regions of
active proliferation as the embryo transitions to larval neurogenesis,
demonstrating that Rbbp4 is required for survival of neural
precursors (Fig. 5I). The failure of rbbp4Δ4/Δ4 neural precursors
to survive explains the reduced eye and microcephaly observed in
mutant larvae. In contrast to rbbp4, which showed significant high
levels of apoptotic cells, the amount of apoptosis in the 2 dpf
hdac1Δ4/Δ4 mutant was not statistically different from wild type
(Fig. 5J,K,L; Table S9). However, the size of the tectum and
thalamus was reduced compared with wild type, with a decrease in
the amount of HuC/D-expressing neurons in the parenchyma
(Fig. 5J). The absence of apoptosis combined with an overall
reduced size suggests that hdac1 is required for persistent
proliferation of stem cells to generate the neural progenitor pool
and new neurons. These results show a distinct requirement for
rbbp4 in neural progenitor or precursor survival, whereas hdac1 is
Fig. 3. Cell-autonomous requirement for RB1 in blocking cell cycle entry in zebrafish neural precursors. Immunolabeling of 5 dpf host larval brain sections
containing descendants of +/+; ubi:DsRed2 and rb1Δ7/Δ7; ubi:DsRed2 donor transplanted cells. n=3 individual transplant experiments for each donor genotype.
(A-D) Phosphohistone H3- and DsRed2-labeled sections through the midbrain optic tectum (OT), thalamus (Th) and retinas (R). Wild-type (A,B) and rb1Δ7/Δ7
mutant (C,D) cells present in a wild-type host optic tectum (OT). A few phosphohistone H3-positive rb1Δ7/Δ7 mutant cells can be detected (D, arrows).
(E-H) Neuronal marker HuC/D- andDsRed2-labeled sections.Wild-type (E,F) and rb1Δ7/Δ7mutant (G,H) cells in a host optic tectum express HuC/D. A number of
rb1Δ7/Δ7mutant cells with highly condensed chromatin lack HuC/D labeling (H, arrows). (I-J) Boxed region in F, showing HuC/D- and DsRed2-positive wild-type
cells with interphase chromatin. (M-P) Boxed region in H, showing that DsRed2-positive rb1Δ7/Δ7 mutant cells with interphase chromatin also express HuC/D.
HuC/D is absent from rb1Δ7/Δ7 mutant cells with highly condensed chromatin (arrows). Scale bars: 100 µm (A,C,E,G); 20 µm (B,D,F,H); 10 µm (I,M).
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necessary for maintaining proliferation of the neural stem and/or
progenitor pool. Similar roles in neural progenitor proliferation
and survival could drive unregulated tumor growth in zebrafish
rb1 brain tumors.
Somatic targeting assay to examine the requirement for
chromatin remodelers in neural stem and progenitor cells
during development
CRISPR-Cas9 somatic targeting in zebrafish provides a simple and
rapid method to investigate the function of a gene during embryonic
and larval development. We developed an in vivo live animal
imaging assay to examine the role of chromatin remodelers and
other candidate tumor suppressor genes in neural stem and
progenitor cells during brain development (Fig. 6A). CRISPR-
Cas9 somatic targeting is performed in the Tg(H2A.F/Z-GFP)
reporter line (Pauls et al., 2001), which expresses a histone H2A.F/
Z-GFP fusion protein that labels chromatin in all nuclei. We
validated the assay by somatic targeting of rb1, rbbp4 and hdac1,
and comparing the phenotype in live 5 dpf larvae with the fixed
immunohistochemical analysis of homozygous germline mutants
(Fig. 6C-E). CRISPR targeting of rbbp4 and hdac1 resulted in gross
defects in the head, consistent with the phenotype of stable germline
loss of function mutants described above (Fig. 6D,E).
To examine the effects of somatic targeting on neurogenesis at the
cellular level, we imaged the optic tectum in live Tg(H2A.F/Z-GFP)
5 dpf uninjected (Fig. 6F), rb1 CRISPR-targeted (Fig. 6G), rbbp4
CRISPR-targeted (Fig. 6H) and hdac1 CRISPR-targeted (Fig. 6I)
larvae. Larvae were mounted with dorsal side upright. A confocal
z-stack of 11 slices was collected at 3 μm steps, beginning ∼30 μm
below the surface of the tectum, moving ventrally towards the
thalamic region. In this ventral region of the tectum, the rate of stem
cell division has slowed dramatically compared with the actively
proliferative zone at the dorsal side. In wild-type larvae, a single
confocal slice through the ventral tectum shows the highly organized
radial pattern of neuronal nuclei extending laterally away from the
midline. A clear demarcation of cells lining the ventricle marks the
midline (Fig. 6F). In the larval midbrain, stem cells line the ventricles
and the anterior-lateral surface of the tectum. In the confocal section
shown, a single metaphase mitotic figure is present near the anterior
side of the uninjected wild-type tectum (Fig. 6F, arrowhead).
Quantification of mitotic figures in 11 wild-type sections showed
14-23 dividing cells per individual tectum (n=3) (Fig. 6J; Table S10).
Live imaging of the tectum in rb1 CRISPR-targeted larvae
showed a dramatic increase in the number of cells with condensed
chromatin (Fig. 6G, arrowheads), consistent with the
phosphohistone H3 immunolabeling results from rb1/rb1 mutant
fixed, sectioned tissue. The M-phase cells were located near the
ventricle and also distributed throughout the tectum, where the
regular array of postmitotic neuron cell bodies are located. The total
number of cells with condensed chromatin in rb1-targeted embryos
was significantly higher than in wild type, ranging from 76 to 133
(n=3, P=0.0145) (Fig. 6JD; Table S8). The variability in total
number in rb1-targeted larvae might be caused by the degree of
mosaicism and formation of bi-allelic indel mutations, although
Fig. 4. Differential gene expression of transcriptional regulators in rb1 tumor and rb1/rb1 mutant transcriptomes. (A) Comparative analysis of all
differentially expressed transcriptional regulators in rb1 tumor and rb1/rb1 transcriptomes. (B) Heat maps of log2(FPKM) showing relative expression of
components of the NuRD chromatin remodeler, neural progenitor and neurogenic transcription factors in rb1 tumor and rb1/rb1mutant transcriptomes. Tables S3
and S6 contain fold change and P-values calculated using DESeq2. (C,D) Average fold change of rbbp4, hdac1, olig2 and ascl1b measured by qRT-PCR in
triplicate (dark-gray bars) and transcriptome DESeq2 calculated values (light-gray bars) in rb1 tumor tissue versus normal adult brain (C) and 5dpf rb1/rb1mutant
versus wild-type larvae (D). metap1, housekeeping gene used as a standard control for heat maps and qRT-PCR.
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genotyping indicated that each was efficiently mutagenized at the
CRISPR target site (Fig. 6K). These results suggest that rb1/rb1
mutant neural precursors can re-enter the cell cycle after migration
into the postmitotic region of the tectum.
To examine the behavior of rb1 mutant neural precursors in real
time, time-lapse confocal images were captured of H2A-GFP in
wild-type and homozygous mutant rb1Δ7/Δ7 larval brains
(Movies 1 and 2, Fig. S9B). Live imaging of the dorsal surface of
the optic tectum in wild type at 3 dpf (Movie 1) and 5 dpf (Movie 2)
shows that the tissue is highly proliferative, with multiple stem cells
entering and completing mitosis. At 5 dpf, in more ventral regions
of the tectum where tissue growth has slowed, a 2-h time lapse
showed quiescent neural precursors, and only one stem cell at the
periphery was captured undergoing mitosis (Movie 3). In contrast,
in the rb1Δ7/Δ7 mutant, multiple cells throughout the tectum
underwent chromosome condensation (Movie 4). Over the course of
3 h, cells that had entered the cell cycle failed to progress through
metaphase, and frequently appeared to be removed by microglia.
Fig. 5. Requirement for chromatin remodelers rbbp4 and hdac1 in zebrafish neurogenesis. (A) CRISPR target site in exon 2 of rbbp4 used to isolate 4 bp
frameshift mutation rbbp4Δ4-is60. PAM sequence is underlined. SmlI restriction enzyme site overlapping the target site is shown in red. (B) 5 dpf wild-type (+/+)
larva. (C) Gross phenotype of 5 dpf homozygous mutant rbbp4Δ4/Δ4 larva showing microcephaly and microphthalmia. (D) CRISPR target site in exon 5 of
hdac1 used to isolate 4 bp frameshift mutation hdac1Δ4-is70. PAM sequence is underlined. (E) 3 dpf wild-type larva. (F) Gross phenotype of 3 dpf homozygous
mutant hdac1Δ4/Δ4 larva showing microcephaly and retinal coloboma (arrow). (G) Diagram of 2 dpf larval midbrain and retina. (H-J) Sections of wild-type (H),
rbbp4Δ4/Δ4 (I) and hdac1Δ4/Δ4 (J) 2 dpf larval heads labeled with neural differentiation marker HuC/D (red) and apoptosis marker activated caspase 3 (green).
In rbbp4Δ4/Δ4, apoptosis is present in the dorsal and lateral tectum (arrows), and throughout the inner retina (brackets) (I). hdac1Δ4/Δ4 larval brain and
retina are smaller than wild type, but few apoptotic cells are detected in the brain or retina (J). (K,L) Quantification of activated caspase 3 in the midbrain (K) and
retina (L) of 2 dpf wild-type, rbbp4Δ4/Δ4 and hdac1Δ4/Δ4 larvae. OT, optic tectum; Th, thalamus; R, retina. Scale bars: 500 µm (B,C); 200 µm (E,F); 100 µm (H-J).
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These analyses confirmed in real time the requirement for zebrafish
Rb1 in blocking neural precursor cell cycle re-entry, and support an
additional role for rb1 in promoting metaphase progression and
completion of mitosis.
The role of zebrafish Rbbp4 and Hdac1 in neural cell populations
during neurogenesis was also examined by live imaging in CRISPR-
targeted larvae. Quantification confirmed that proliferation in the
tectum was not significantly different from wild type after targeting
Fig. 6. CRISPR somatic targeting-live imaging assay to test chromatin remodeler function in neural cell populations during brain development.Somatic
inactivation recapitulates germline mutants and reveals distinct requirements for rb1, rbbp4 and hdac1 in neural progenitor proliferation, differentiation and
survival. (A) CRISPR targeting in histone H2A.F/Z-GFP fusion line and dorsal view, and confocal live imaging of GFP in the brain at 5 dpf. (B) 5 dpf wild-type
larvae. (C-E) Gross defects in 5 dpf rb1 (C), rbbp4 (D) and hdac1 (E); CRISPR targeted larvae recapitulate germline phenotypes. (F) Confocal imaging in the optic
tectum in the brain of a live 5 dpf larva. Section through the ventral region of the optic tectum. Mitotic figures are rarely captured in uninjected larvae at this level of
the tectum (red arrowhead). (G) Tectum in rb1 CRISPR-targeted larva shows cells with nuclei containing condensed chromatin (red arrowheads) scattered
throughout the postmitotic region of the tissue. (H) Tectum in rbbp4 CRISPR-targeted larva shows intense, punctate fluorescence in presumed apoptotic nuclei
(red arrowheads) and abnormally large, irregular nuclei (asterisks). (I) Tectum in hdac1CRISPR targeted larva shows an overall reduction in size and cell number.
Enlarged nuclei with faint GFP line in the ventricle (red arrowheads) are observed. (J) Quantification of M-phase phosphohistoneH3-positive nuclei in the optic
tectum in three uninjected control, rb1-, rbbp4- and hdac1-targeted larvae. Targeting experiments were replicated three times for rb1, and two times for rbbp4 and
hdac1. Plot shows mean±s.e.m. number of positive nuclei in 11 sections, in three biological replicates. The number of M-phase nuclei in rb1-targeted larvae is
significantly different from that in control larvae. rb1, P=0.0145; rbbp4, P=0.3024; hdac1, P=0.1841; n.s., nonsignificant (two-tailed unpaired Student’s t-test).
(K-M) PCR genotyping shows highly efficient mutagenesis in the three CRISPR-targeted individuals used for quantification. C, control uninjected individuals.
Location of rb1 exon 2 CRISPR gRNA and ClaI enzyme site overlapping Cas9 cut site (K). U, undigested PCR amplicon; D, ClaI-digested PCR amplicon
surrounding exon 2. rbbp4 and hdac1 targeting was performed with the gRNAs used to isolate loss of function alleles described in Fig. 5. rbbp4 targeting (L). U,
undigested exon 2 PCR amplicon; D, SmlI-digested exon 2 PCR amplicon. In the hdac1-targeted larvae the diffuse PCR amplicon band on the gel in targeted
individuals correlates with efficient mutagenesis (M). Scale bars: 200 µm (A-E); 50 µm (F-I).
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rbbp4 (1-9 cells per larva; n=3, P=0.3024) (Fig. 6H,J,L; Table S8). In
rbbp4-targeted larvae, cell nuclei throughout the tectum appeared
fragmented or hypercondensed, reminiscent of cells undergoing
apoptosis (Fig. 6H, arrowheads). Frequently, very enlarged nuclei or
cells were detected near the tectum posterior border (Fig. 6H,
asterisks). Like the analysis of fixed tissue from homozygous
mutants, live imaging of the rbbp4-targeted larval brain revealed that
rbbp4 is required for survival of newborn or postmitotic neurons.
hdac1 CRISPR-targeted larvae (Fig. 6I,M) also showed a
consistent neurogenic phenotype, but a range of severities. In
some larvae the optic tectum was reduced in size, while in others the
midbrain ventricle was completely open and tectal structures
entirely missing. Imaging of hadc1-targeted larvae that had
developed an optic tectum revealed no significant difference in
the number of mitotic cells compared with wild type (3-17 cells per
larva; n=3, P=0.1841) (Fig. 6I,J; Table S8). However, the nuclei in
cells lining the ventricle appeared enlarged, with diffuse GFP
expression (Fig. 6I, arrowheads), indicating that the chromatin was
decondensed. The reduced size of the brain, together with
decondensed chromatin in cells lining the ventricle, suggests that
the neural stem cells in the hdac1-targeted larvae had exited the cell
cycle and become quiescent. These results support a requirement for
hdac1 in maintenance of a proliferating neural stem cell population.
Our CRISPR somatic targeting-live imaging assay is a simple,
rapid method to test the function of transcriptional regulators in
neural cells and gain additional insight into their roles in tumor cell
proliferation and oncogenesis. The somatic targeting assay confirms
the germline mutant phenotype and reveals a dynamic view of
proliferation and commitment in neural cell populations in the
developing midbrain (Fig. 7). Our analyses suggest that rb1 is
necessary to block re-entry of neural precursors into the cell cycle.
In the absence of rbbp4, neural precursors fail to survive and
activate caspase 3-mediated apoptosis. The production of new
neural precursors is dependent on hdac1 maintaining proliferation
of the neural stem cell pool. Together, these results suggest that
elevated expression of rbbp4 and hdac1 after rb1 loss drive
unregulated proliferation and growth in zebrafish rb1 brain tumors.
DISCUSSION
In this study, we compared the transcriptome of somatically
engineered zebrafish rb1 primitive neuroectodermal-like brain
tumors with homozygous rb1/rb1 mutants and identified
epigenetic regulators that could contribute to the mechanism of
RB1 mutant tumor oncogenesis. Our results suggest that
transcriptional regulation by epigenetic modifiers and neural
progenitor transcription factors distinguishes transformed RB1
mutant tumor cells from homozygous mutant brain tissue harboring
a simple loss-of-function mutation in rb1. We next performed
phenotypic mutant analysis in the developing zebrafish larval brain
to understand the role of rb1 and the chromatin remodelers rbbp4
and hdac1 in normal neurogenesis. As part of this analysis, we
developed a novel in vivo assay to examine RB1 and chromatin
remodelers in neural precursor proliferation, survival and
differentiation. The results show a cell-autonomous requirement
for rb1 in blocking cell cycle re-entry in neural precursors. While
rbbp4 is required for neural progenitor and/or precursor survival,
hdac1 is necessary for maintaining proliferation of the neural stem/
progenitor pool. The requirements for rbbp4 and hdac1 in
regulating neural progenitor proliferation and survival might
contribute to oncogenesis after rb1 loss in zebrafish rb1 brain
tumors. Our study provides novel insights into the tumor
suppressive role of zebrafish Rb1 and its candidate interacting
proteins Rbbp4 and Hdac1 in driving persistent tumor growth, and
identifies Rbbp4 as a potential target to inhibit tumor cell survival.
Our zebrafish rb1 brain tumor model histologically and
molecularly resembles human CNS-PNET, an embryonal tumor
composed of proliferative neuroblast cells. Conditional Rb1
knockout in mice neural precursors in combination with Tp53
(Trp53) and Pten tumor suppressors favors formation of CNS-
PNET over glioma (Chow et al., 2011; Jacques et al., 2010).
Although our zebrafish model results from inactivation of a single
tumor suppressor rb1, tumor pathway analysis identified TP53-
dependent signaling, DNA mismatch, base excision and
homologous recombination repair pathways as altered in rb1
tumors, and these factors might contribute to transformation and
tumorigenesis. In humans, CNS-PNET has been genetically linked
to mutation or alteration of RB1/E2F, TP53 and DNA mismatch
Fig. 7. Roles for rb1 and chromatin regulators rbbp4 and hdac1 in
proliferation, survival and terminal differentiation during neurogenesis.
Diagram of spatial organization of neurogenesis in the zebrafish midbrain. In
the midbrain, stem cells in the optic tectum (OT) and thalamus (Th) line the
ventricles and undergo self-renewing divisions to produce progenitors.
Progenitors exit the cell cycle, and neural precursors migrate to their final
destination in the parenchyma, where they differentiate into mature neurons.
Germline mutant and CRISPR somatic-targeting analyses showed that
zebrafish rb1 is required cell autonomously to prevent neural precursor cell
cycle re-entry. rbbp4 is required for survival of neural precursors. hdac1 is
necessary to maintain proliferation in the stem cell pool, possibly by preventing
premature cell cycle exit and differentiation, and/or quiescence.
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repair pathways (reviewed in Larson and Largaespada, 2012). It has
been reported that 4-15% of children carrying RB1 mutations
develop PNETs outside of the retina (Blach et al., 1994; de Jong
et al., 2015; Kivelä, 1999), and that silencing of CDKN2A, a
negative regulator of RB1-inhibiting cyclin-dependent kinases,
occurs in sporadic PNETs (Li et al., 2005; Pfister et al., 2007).
Sporadic CNS-PNET has also been associated with TP53 mutation
and overexpression (Eberhart et al., 2005) and TP53 germline
mutation in Li Fraumeni syndrome (Orellana et al., 1998). A
number of tumor types, including CNS-PNET, arise in individuals
with Turcot syndrome Type I, which is linked to mutations in the
DNA mismatch repair genes MLH1, MSH2, PMS1 and PMS2 (De
Vos et al., 2004). Altered expression of RB1/E2F, TP53 and DNA
mismatch repair pathways in the zebrafish rb1 brain tumor model is
consistent with the genetic origin of human CNS-PNETs.
Comparative genomics revealed that the zebrafish RB1 brain
tumors are most similar to the human OLIG2+/SOX10+ CNS-
PNET subtype (Picard et al., 2012; Sturm et al., 2016). We
confirmed that Olig2 and Sox10 are highly expressed in tumor
tissue, supporting a mechanism in which oligoneural precursor
transcription factors contribute to gene expression driving tumor
cell proliferation. The previous observations that epigenetic
mechanisms drive cell transformation and tumorigenesis in
human and mouse retinoblastoma (Aldiri et al., 2017; Benavente
et al., 2013; Zhang et al., 2012) suggested that epigenome changes
also underlie oncogenesis in the zebrafish rb1 tumor model.
Differential gene expression showed that >36% of all transcriptional
regulators, including >170 chromatin remodelers, are altered in the
rb1 tumor transcriptome, which suggests epigenetic control of gene
expression drives tumorigenesis. RBBP4, a chromatin adaptor for
multiple chromatin remodeling complexes, is an E2F target and, as
expected, was increased in the zebrafish rb1 tumor and rb1/rb1
homozygous mutant transcriptome. hdac1, which is not a direct
target of E2F transcriptional activation, was highly upregulated in
the tumor transcriptome, but only elevated 1.3-fold in the rb1/rb1
mutant. This suggests that hdac1 is one of many chromatin
remodelers for which activity might distinguish transformed tumor
cells from mutant cells. Gene regulatory network analysis and
simulation of tumorigenesis in a human cell line model has
suggested that chromatin remodelers cooperate with transcription
factors as cells progress to transformation (Malysheva et al., 2016).
A similar epigenetic mechanism in which Hdac1 and Rbbp4
associate with oligoneural precursor transcription factors might
drive zebrafish rb1 brain tumor oncogenesis.
Our analysis of zebrafish loss-of-function rb1/rb1 mutants in
neural development reveals a cell-autonomous requirement for rb1
in suppressing cell cycle re-entry in neural precursors. This is
consistent with the original mouse Rb1 knockout models
demonstrating ectopic proliferation in the embryonic mouse brain
(Clarke et al., 1992; Ferguson and Slack, 2001; Jacks et al., 1992;
Lee et al., 1992; Lipinski and Jacks, 1999). More recently,
conditional Rb1 knockout in embryonic and adult mouse neural
progenitors has shown that Rb1 is required to control neural
precursor proliferation and for the long-term survival of newborn
neurons in the olfactory bulb and hippocampus (Naser et al., 2016;
Vandenbosch et al., 2016). Although our results do not indicate that
zebrafish Rb1 functions in long-term neuron survival, analysis of
rb1/rb1mutant cells over an extended timewould be required to rule
out this role. Our live imaging of histone H2A-GFP in zebrafish
larval brain allowed a dynamic view of rb1/rb1 mutant neural
precursor behavior and cell cycle entry. Following chromatin
condensation, rb1/rb1 mutant cells failed to progress through
mitosis and appeared to idle in prometaphase, indicating that RB1 is
also required to complete the cell cycle. A delay in cell cycle exit of
retinal ganglion cell precursors was previously reported in the
zebrafish rb1 mutant space cadet (Gyda et al., 2012). Whether rb1/
rb1mutant neural precursors remain arrested inM phase, eventually
exit the cell cycle, or undergo continuous rounds of inappropriate
cell cycle entry will require additional analyses.
Recently, RB1 has been shown to cooperate with the DREAM
complex subunit Lin37 to block cell cycle entry and transition cells
from G1 to G0/quiescence (Mages et al., 2017). In budding yeast,
the transition from proliferation to quiescence is mediated by
DREAM recruitment of the histone deacetylase HDAC1 to S-phase
genes to repress cell cycle entry (Miles and Breeden, 2017), again
connecting RB1 with chromatin remodeling in cell cycle regulation.
RB1 has also been shown to interact genetically with the chromatin
remodeler histone demethylase UTX in cell fate control in
Caenorhabditis elegans (Wang et al., 2010a). Zebrafish rb1/rb1
mutant neural precursors fail to initiate quiescence, but our data
showed this also lack the ability to respond to differentiation signals
in the environment. RB1 in association with HDAC1 and other
chromatin remodelers might be required to shift the gene expression
program in G1 neural precursors to a neural differentiation program.
The disruption of RB1-dependent transcriptional mechanisms
controlling neural precursor quiescence and differentiation could
be a part of oncogenesis in RB1 mutant brain tumors.
The zebrafish rbbp4 and hdac1 mutants we isolated and
characterized have provided new insight into their roles in neural
cell fate decisions. RBBP4 has not previously been studied in the
developing vertebrate nervous system, and our analysis shows that
rbbp4 is necessary for neural precursor survival in zebrafish.
RBBP4 acts as a chromatin adaptor for multiple chromatin
regulatory complexes, including HDAC1/NuRD (Alqarni et al.,
2014), PRC2 (Kuzmichev et al., 2002; Müller et al., 2002),
DREAM/MuvB (Harrison et al., 2006; Litovchick et al., 2007) and
the transcriptional activator p300/histone acetyl transferase
(Kitange et al., 2016). In zebrafish neural precursors, Rbbp4
could assist in genomemaintenance through p300 activation of gene
expression in DNA repair pathways, as was reported in glioblastoma
cells (Kitange et al., 2016). Additional phenotype and genetic
interaction studies of zebrafish rbbp4 are necessary to dissect the
contribution of RBBP4 and its chromatin remodeling complexes to
preventing neural precursor apoptosis and facilitating neural
differentiation. Like RBBP4, HDAC1 is a component of multiple
chromatin remodeling complexes that function separately to control
proliferation and differentiation, depending on the cell type and
context. The zebrafish hdac1 mutant phenotype would support a
role for HDAC1 in maintaining stem cell proliferation and the
production of neural progenitors, either by blocking quiescence or
premature differentiation in the stem cell population. The
decondensed, enlarged nuclear phenotype of zebrafish hdac1
mutant stem cells in the brain suggests that histone deacetylation
is important for maintaining a proliferative stem cell pool. Global
loss of histone acetylation owing to overexpression of HDAC
proteins is a common feature in several human cancers (Haery et al.
2015). Together with the survival-promoting activity of RBBP4,
HDAC1 and RBBP4 might cooperate to drive persistent
proliferation and growth of tumor cells in RB1 mutant brain cancer.
Future studies to investigate the cooperation of RBBP4, HDAC1
and RB1 in specific neural precursor cell types will increase
understanding of the mechanisms by which RBBP4 prevents
programmed cell death and HDAC1 maintains a balance between
proliferation and differentiation and/or quiescence. Since the first
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description of somatic targeting in zebrafish using custom genome
editing nucleases (Bedell et al., 2012), CRISPR/Cas9 and TALENs
have beenwidely adopted to examine developmental mechanisms and
model disease (Peng et al., 2014; Shah et al., 2016). Combined with
the histone-GFP reporter live imaging assay we developed, our
somatic screen provides a rapid method to test chromatin remodelers
and further dissect the mechanism controlling RB1-dependent
proliferation and survival in neurogenesis and tumor suppression.
The recent discovery of a WD40-repeat inhibitor that binds the MLL
subunit of PRC2 (Song et al., 2017) suggests that otherWDRproteins,
such as RBBP4, are strong candidates for chemical compound
screening to identify therapeutic drugs. Given the requirement for
RBBP4 in neural precursor survival, RBBP4 and its associated
chromatin remodeling complexes represent a potential new target to
inhibit tumor cells and induce neural cancer cell apoptosis.
MATERIALS AND METHODS
Zebrafish care and husbandry
Zebrafish were raised in an Aquatic Habitat housing system from Pentair
Aquatic Eco-systems and maintained at 27°C on a 14 h light/10 h dark
cycle. The zebrafish WIK wild-type strain and transparent casper mutant
line (White et al., 2008) were purchased from the Zebrafish International
Resource Center (https://zebrafish.org/home/guide.php). Transgenic line
Tg(H2A.F/Z-GFP) (Pauls et al., 2001) was received from Dr Brian Link,
Medical College of Wisconsin. Isolation of the zebrafish rb1 7 bp exon 2
frameshift mutation rb1Δ7is54 was described previously (Solin et al.,
2015). All experimental protocols were approved by the Iowa State
University (ISU) Animal Care and Use Committee (Log#11-06-6252) and
performed in compliance with American Veterinary Medical Association
and National Institutes of Health (NIH) guidelines for the humane use of
laboratory animals in research. The zebrafish rb1 brain tumor model was
generated by injection of rb1 TALENs targeting exon 2 (Solin et al., 2015).
Animals were monitored according to the guidelines for endpoint in
neoplasia studies as outlined in the NIH/Office of Animal Care and Use/
Animal Research Advisory committee (ARAC) Guidelines for endpoint in
neoplasia studies (oacu.od.nih.gov/ARAC/Guidelines for Endpoints in
Animal Study Proposals). Adult fish were monitored daily during feeding
for general appearance, size, length, viability and morbidity relative to
control siblings. Fish were monitored bi-weekly for evidence of cranial
tumors, and sacrificed before tumor burden reached 3 mm in size/25 mg in
weight, constituting less than 10% of the total body weight of an adult fish
(300-500 mg).
RNA-Seq libraries, sequencing and analysis
Zebrafish rb1 brain tumor model RNA-Seq libraries
Tissues for isolation of total RNA were dissected from ten adult fish with
brain tumors and six control wild-type siblings aged 6.5-10.5 months. One
sagittal half of each brain from the diencephalon to behind the cerebellum
was isolated for RNA extraction. The remaining half was processed and
embedded in either paraffin blocks or OCT media (Thermo Fisher
Scientific). Total RNA was isolated using TRIzol (Invitrogen), followed
by DNase I (Qiagen) digestion and Qiagen RNeasy MinElute Cleanup
(Qiagen). RNA quality was analyzed with the Agilent RNA 6000 Nano Kit
on an Agilent 2100 Bioanalyzer. One microgram of total RNA input was
used for each library preparation. Replicate cDNA libraries were synthesized
from ten individual brain tumor RNA samples and two pools of three wild-
type brain RNA samples using the Illumina TruSeq RNA Library Prep Kit
v2., for a total of 24 barcode-indexed libraries. The 24 cDNA libraries were
multiplex 50 bp single-end sequenced in two lanes (12 per lane) on an
Illumina HiSeq 2500 instrument at the Genome Sequencing Core, Center for
Molecular Analysis of Disease Pathways, University of Kansas.
Zebrafish rb1Δ7/Δ7 mutant 5 dpf larval brain RNA-Seq libraries
Heterozygous rb1Δ7/+ adults were in-crossed and embryos aged to 5 dpf
for tissue isolation. Individual 5 dpf larvae were dissected in two; the head
was placed in TRIzol for storage at −80°C; the trunk was placed in 50 mM
NaOH, heated at 95°C for 30 min, and used for PCR genotyping. Three
pools of five genotyped heads were used to prepare three wild-type +/+ and
three rb1Δ7/Δ7 homozygous mutant barcoded indexed RNA-Seq libraries,
as described above. The six indexed libraries were multiplex 50 bp single-
end sequenced in two lanes on an Illumina HiSeq 2500 instrument at the
Genome Sequencing Core, Center for Molecular Analysis of Disease
Pathways, University of Kansas.
Reads were aligned to the GRCz10 zebrafish reference genome using
GSNAP version 20150723 with the following parameters ‘-N 1 -t 8 -B 4 -m
5 -A sam –split-output’ to account for exon-exon splice junctions during
alignment and a maximum of five mismatches. The ‘uniq’ SAM output files
from GSNAP were funneled through Cufflinks 2.2.1 for normalization.
Python HT-Seq 0.9.1 was used to generate the count table from the
GSNAP ‘uniq’ SAM files. Gene exonic length was calculated from the
Danio_rerio.GRCz10.89.gtf file in R using the ‘GenomicFeatures’ package
from Bioconductor. Calculation of fragments per kilobase of transcript per
million mapped reads (FPKM) was performed using the following equation:
FPKM=(109×number of mapped reads to a gene)/(gene exonic length×total
mapped reads in the experiment). Count data generated from HT-Seq were
analyzed for differential gene expression detection using DESeq2.
Differentially expressed genes were defined by an adjusted P-value of less
than or equal to 0.01 and a 1.5-fold change in either direction.
Correlation coefficient plots were computed using FPKM in Microsoft
Excel with the CORREL function. GSEA and E2F target gene analysis was
performed at the Broad Institute website (http://software.broadinstitute.org/
gsea/index.jsp). IPA (830036, Qiagen) was performed with software
licensed to ISU. For IPA, human homologs of zebrafish genes were
identified at Biomart (http://www.biomart.org). Differential gene
expression of 3302 transcriptional regulators was analyzed using the gene
list identified in Armant et al. (2013). Heatmaps were generated in R with
gplots heatmaps.2 or with Broad Institute GENE-E software (https://
software.broadinstitute.org/GENE-E/). Venn diagrams were drawn at http://
www.venndiagrams.net.
qRT-PCR
Larvae at 5 dpf from an in-cross between rb1Δ7/+ adults were collected and
dissected into head and trunk tissue. Head tissue was placed in TRIzol.
Trunk tissue was digested in 50 mM NaOH at 95°C for 30 min, then PCR
genotyped to identify homozygous rb1Δ7/Δ7 and wild-type +/+ siblings.
Thirty-three homozygous rb1Δ7/Δ7 heads and 40 +/+ heads were pooled,
and total RNA extracted. mRNA was purified from total RNA using a
magnetic isolation kit (E7490S, NEB) and checked for quality using an
Agilent 2100 Bioanalyzer. First-strand cDNA was reverse transcribed with
SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (11752-050,
Invitrogen). qRT-PCR primers are listed in Table S8. Quantitative PCR
(qPCR) reactions were set up with SYBR Green (A25742, Applied
Biosystems) and a final primer concentration 200 nM. qPCR was run with
standard temperature settings on a Roche Lightcycler 480 instrument at the
ISU Genome Technology Facility.
Histology and immunolocalization
For histological analysis tumor tissue was fixed in 10% formalin, paraffin-
embedded, microtome sections (6 µm) stained with Hematoxylin 7211
Richard-Allan Scientific (Thermo Fisher Scientific) and 3% Eosin Y
(152880250, Argos Organics). For immunolocalization, tumor tissue and
larval heads were fixed in 4% paraformaldehyde, embedded in Tissue-Tek
OCT 4583 (Thermo Fisher Scientific) and sectioned at 16-20 µm.
Cryosections were labeled with the following antibodies: rabbit
polyclonal anti-phosphohistone H3 (9701, Cell Signaling Technology) at
1:1000; rabbit polyclonal anti-SOX2 (AB5603, EMD Millipore) at 1:200;
rabbit polyclonal anti-SOX10 (GTX128374, GeneTex) at 1:200; rabbit
polyclonal anti-OLIG2 (18953, IBL America) at 1:200; mouse monoclonal
anti-HuC/HuD (A-21271, Invitrogen) at 1:300; rabbit polyclonal Living
Colors DsRed (632496, Clonetech) at 1:200; rabbit anti-activated human
caspase 3 (559565, BD Pharmingen) at 1:500. Alexa Fluor 488 (A-11008,
Invitrogen)- and Alexa Fluor 594 (A-11005, Invitrogen)-conjugated
secondary antibodies were used at a dilution of 1:500. Sections were
stained with DAPI and mounted in Fluoro-Gel II containing DAPI (17985-
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50, Electron Microscopy Sciences). Immunolabeled sections were imaged
on a Zeiss LSM700 laser scanning confocal microscope with 10×, 20×, 40×
C-apochromat and 63× plan-apochromat objectives. Images and figures
were assembled in Adobe Photoshop.
Isolation of Tol2<ubi:DsRed2> transgenic line
The Tol2<ubi:DsRed2> transgene was assembled in the mini-pTol2 vector
(Balciunas et al., 2006) by cloning in the zebrafish ubiquitin promoter
(Mosimann et al., 2011) followed by the DsRed2 cDNA (Clonetech) and the
zebrafish β-actin 3′UTR (Dr Darius Balciunas, Temple University) (McGrail
et al., 2011). One microgram of linearized pT3TS-Tol2 transposase plasmid
(Balciunas et al., 2006) was used for in vitro synthesis of Tol2 transposase-
capped, polyadenylated mRNA using the T3 mMessage mMachine High
Yield Capped RNA transcription kit (AM1348, Ambion). mRNA was
precipitated with LiCl and resuspended in RNase, DNase-free molecular-
grade water. The Tol2<ubi:DsRed2> transgenic line was isolated by co-
injection of 25 pg Tol2 vector plus 100 pg Tol2 mRNA into one-cell-stage
zebrafish embryos. Two founder fish were screened for germline transmission
of ubiquitously expressed DsRed2. The Tg(Tol2<ubi:DsRed2>)is56 line was
established from a single F1 adult.
Blastula cell transplants to create genetic mosaic zebrafish
embryos
Transplant of cells from blastula-stage embryos was performed as described
previously (Wang et al., 2010b); 30-50 cells from blastula stage embryos
from adult rb1Δ7/+ crossed to rb1Δ7i/+; Tg(Tol2<ubi:DsRed2>)is56 were
transplanted into blastula-stage casper host embryos, and the remaining
donor blastula tissue was used for genotyping. Host embryos were screened
for DsRed2-positive fluorescence at 24 and 48 hours postfertilization (hpf).
Three host embryos containing DsRed2-expressing transplanted cells from
three individual donor embryos of wild-type +/+ or homozygous mutant
rb1Δ7/Δ7 genotype were aged to 5 dpf. Larval heads were dissected, fixed,
embedded, sectioned and immunolabeled for confocal imaging as described
above.
CRISPR-Cas9 guide RNAs and isolation of loss of function rbbp4
and hdac1mutations
The following CRISPR guide RNAs (gRNAs) were used for somatic
targeting of zebrafish: rb1, rbbp4 and hdac1. rbbp4 and hdac1 gRNAs were
also used to isolate the stable germline 4 bp frameshift mutations rbbp4Δ4-
is60 and hdac1Δ4-is70. The rb1 exon 2 CRISPR site 5′-GGAGAGGGAG-
ATCAGATCGA-3′ contains a ClaI restriction enzyme site overlapping the
Cas9 cut site upstream of the protospacer adjacent motif (PAM). The rbbp4
exon 2 CRISPR site 5′-GATGACCCACGCCCTTGAG-3′ has a SmlI
restriction enzyme site overlapping the Cas9 cut site. For hdac1, the exon 5
CRISPR site 5′-GACAGACAGTGCCATTAAC-3′ was used for targeting.
CRISPR gRNAs were prepared by the cloning-free single-guide RNA
synthesis method (Varshney et al., 2015) using Ambion T7 MEGAscript Kit
(AM1334M, Ambion) and purified with the Qiagen miRNeasy Kit (217004,
Qiagen). Cas9 mRNA was synthesized in vitro using the mMessage
mMachine T3 kit (AM1348, Life Technologies). Then, 5-10 μg of pT3TS-
nlsCas9nls plasmid (46767, Addgene) was linearized with XbaI and purified
with Qiaquick Spin kit (28104, Qiagen), 500 ng to 1 μg purified linear
pT3T3-nlsCas9nls DNA was used as template for mRNA synthesis, and the
capped nls-Cas9-nls mRNA was purified with the miRNeasy kit (Qiagen
217004).
Primers for amplicons to test for mutagenesis were as follows: rb1
Forward 5′-TTTCCAGACACAAGGACAAGGATCC-3′, Reverse 5′-GC-
AGATATCAGAAGAAAGAGTACATTTGTCTT-3′; rbbp4 Forward 5′-
GCGTGATGACAGATCTCATATTGTTTTCCC-3′, Reverse 5′-CTGGT-
GACATCTGGCAACCACT-3′; hdac1 Forward 5′-GCGGTGAAACTCA-
ACAAACA-3′, Reverse 5′-GAATGGCCAGTACAATGTCG-3′.
To isolate stable germline mutations, 25 pg rbbp4 or hdac1 CRISPR
guides were co-injected with 150 pg Cas9 mRNA into WIK embryos. Eight
to ten targeted embryos were tested for mutagenesis by PCR genotyping,
and sibling founders raised to adulthood. Adult founder fish were outcrossed
to wild-type WIK fish and F1 embryos screened for inheritance of stable
germline mutant alleles. Sibling F1 progeny were raised to adulthood
and heterozygotes identified by genotyping of fin clip tissue. F2 families
of heterozygous mutant fish were established by outcrossing to
wild-type WIK.
CRISPR somatic targeting and larval brain live imaging
CRISPR gRNAs were co-injected with 150 pg Cas mRNA into one-cell
Tg(H2A.F/Z-GFP) embryos. At 12 hpf, embryos were placed in (0.003%)
30 mg/l phenyl-thio-urea (PTU) to inhibit melanin synthesis. Larvae at 5 dpf
were mounted in 1.2% low-melt agarose containing 160 μg/ml tricaine
methanesulfonate ventral side down on coverslip-bottom 35-mm petri dishes.
The dish was filled with embryowater (Westerfield, 1995) containing tricaine
and PTU. Live larvae were imaged on a Zeiss LSM700 laser scanning
confocal microscope using a 40×W-NAchroplan water immersion objective.
Z series containing 11 sections were captured beginning ∼30 μm below the
dorsal side of the optic tectum and descending ventrally at 3-μm intervals.
Three control uninjectedTg(H2A.F/Z-GFP) larvae and three CRISPR gRNA-
injected Tg(H2A.F/Z-GFP) larvae for each gene were imaged. After imaging,
larvaewere digested in 50 mMNaOHand genotyped by PCR.Mitotic figures
in each section were counted in ImageJ. Mitotic figure quantification was
plotted and the significance calculated using a two-tailed unpaired Student’s
t-test in GraphPad Prism 7.0 (GraphPad Software).
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